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Abstract: The synthesis of structurally novel carbohydrate-
flavone and -chromone derivatives with unsaturated carbon 
bridge has been accomplished by phosphine-free palladium 
catalyzed cross-coupling reaction. 
Key words: cross-coupling, catalysis, palladium, Mizoroki-
Heck reaction, isomerism 
The class of natural occurring C-glycosyl flavonoids, 
e.g. vitexin, orientin, isovitexin, isoorientin (Figure 1) 
containing C-glucopyranosyl moiety, has recently 
received a great attention for organic chemists since 
these compounds possess wide variety of biological 
activities e.g. anti-inflammatory activity,
1
 antiviral 
activity.
2
 The antioxidant kurilensin A and B were 
isolated
3
 from hot-water extracts of the leaves of Sasa 
kurilensis as C-glycosyl flavonoids (Figure 1). What 
these compounds have common in that there is always 
one or two activating group, such as hydroxy or 
methoxy group, in position 5 or 7 of the flavone 
skeleton. 
 
Figure 1 Natural occurring flavone C-glycosyl flavonoids. 
The C-glycosyl compounds have an advantage 
comparing to O-glycosides, namely the C-C bond 
enzymatically is not degradable
4
 and this feature could 
be an attractive behavior for pharmaceutical aims. In 
nature only those C-glycosyl flavones are known in 
which the aglycon is directly bonded to the 
carbohydrate unit in one bond distance. Scientist has 
no knowledge about the changes of the biological 
activity due to the modification of the distance 
between the aglycon and the sugar units since the 
synthesis of these compounds have not been studied 
yet.  
In literature, the synthesis of the C-glycosyl flavones 
often starts from acetophenone derivatives which 
already possess the sugar moiety and usually more 
steps are required (e.g. Fries rearrangement or Friedel-
Crafts reaction, Claisen-Schmidt condensation, Baker-
Venkataraman-type rearrangement followed by 
oxidative ring closure)
5-8
 to obtain the target molecule. 
In every step, there is a chance for the degradation of 
the carbohydrate moiety. Although, there are a few 
examples for the direct C-glycosylation of the aglycon 
moiety
9,10
 but usually in these transformation the 
position of the carbohydrate unit is controlled by a 
directing group (e.g. hydroxy). On the basis of these 
limits, we wanted to perform a synthetic 
transformation in which 
a) the sugar part is introduced in the last step and  
b) its position is controlled according to our aim.  
Our goal was to synthesize these molecules by 
utilizing our earlier acquired experiences in the field 
of palladium catalyzed cross-coupling reaction of 
oxygen containing heterocycles e. g. flavones, 
chromones. Namely, our group successfully developed 
useful methods
11-13a
 for the synthesis and 
transformation of chromones and flavones using 
Mizoroki-Heck reaction and its phosphine-free 
version the Jeffery’s conditions.
13b
 As a logical 
continuation of these results, we wished to perform 
the reaction of bromoflavones and -chromones with 
allyl ribofuranose compounds in order to prepare 
flavone/chromone--D-ribofuranose derivatives with 
various unsaturated linker. Moreover, the synthesis of 
these new types of conjugates has not been 
investigated up to now. 
First, 6- and 7-bromoflavone (1a,b) were used as 
starting materials and the reactions were carried out 
under our optimized cross-coupling reaction 
condition.
11,13a
 As terminal alkenes 1-allyl--D-
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ribofuranose derivatives 2a and 2b were used in order 
to provide the carbohydrate unit. 
 
Scheme 1 Reaction of 7- and 6-bromoflavones (1a,b) with 1-allyl-
-D-ribofuranose derivatives 2a,b using Jeffery’s condition 
Table 1 Yields of cross-coupling reaction of 6- and 7-
bromoflavones (1a,b) and -D-riboses 2a and 2b 
Compound Ribose (R) Method Yield 
1a OBn Mizoroki-Heck 63% (3a) 
1a OBn Jeffery’s 89% (3a) 
1a H Jeffery’s 68% (3b) 
1b H Jeffery’s 75% (4b) 
1b OBn Jeffery’s 92% (4a) 
Jeffery’s condition: KCl, Bu4NBr, K2CO3, Pd(OAc)2, dry DMF, 
100-110°C, 1-2 hrs 
Mizoroki-Heck condition: Et3N, PPh3, Pd(OAc)2, NMP, 100-
110°C, 1-2 hrs 
 
Initially, a Mizoroki-Heck type reaction was 
performed with 7-bromoflavone (1a) and 1-allyl--D-
ribofuranose (2a) using Pd(OAc)2/Ph3P and the 
corresponding flavone-ribose compound 3a was 
obtained in 63% yield. Then under phosphine-free 
Jeffery’s condition, the same 3a product was isolated 
in higher yield (89%). Therefore in all further cases 
the phosphine-free condition was applied (Scheme 1, 
Table 1). By comparing the yields of these cross-
coupling reactions in case of 1-allyl--D-ribofuranose 
(2a) and 1-allyl-2-desoxy--D-ribofuranose (2b) 
derivatives, revealed furanose 2a results the products 
in higher yields in all cases. This result could be 
explained by the easier coordination of palladium in 
the presents of OBn group in position 2 as an oxygen 
donor group. 
 
Scheme 2 Reaction of 3-bromoflavone (5) with 1-allyl--D-
ribofuranose derivatives 2a,b 
Table 2 Yields of cross-coupling reaction of 3-bromoflavone (5) 
and -D-riboses 2a and 2b 
Compound R Product 6 Isomer product 7 
2a OBn 21% 20% 
2b H 19% 18% 
 
The transformation of 3-bromoflavone (5) to flavone-
ribofuranose compounds 6a and 6b was also 
successful; in addition a new observation was taken. 
Namely, the palladium catalyzed cross-coupling 
reaction of 3-bromoflavone (5) and 2a resulted in two 
products. The separation of these derivatives was 
successful and the structure elucidation was supported 
by 2D NMR measurements. It is revealed due to the 
migration of the double bond during the reaction, two 
isomers (6a and 7a) were formed approximately in 1:1 
ratio (Scheme 2, Table 2). This isomerism occurred 
only in case of 3-bromoflavone (5) and this type of 
phenomena can be explained by literature,
14
 since in 
case of other allyl derivatives similar isomerism 
occurred in the presence of palladium. 
 
Scheme 3 Reaction of 7- and 6-bromochromones (8a,b) with 1-
allyl--D-ribofuranose derivatives 2a,b 
In order to wider the range of the used oxygen 
containing heteroaromatic derivatives, 
bromochromones 8a,b were reacted with1-allyl-D-
ribofuranose 2a and 2b under Jeffery’s condition. The 
reaction of 6-bromochromone (8b) with ribofuranose 
derivatives 2a and 2b provided compound 10a and 
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10b in moderate yields (44%, 28%). Moreover, the 
reaction of 7-bromochromone (8a) afforded the 
corresponding product 9a,b in good yields (79%, 
49%) (Scheme 3, Table 3). 
Table 3 Yields of cross-coupling reaction of 6- and 7-
bromochromones (8a,b) and -D-riboses 2a and 2b 
Compound Ribose (R) Yield 
8a OBn 79 (9a) 
8a H 49 (9b) 
8b OBn 44 (10a) 
8b H 28 (10b) 
 
The cross-coupling reaction of 3-boromochromone 
(11) was carried out only with terminal alkene 2a. 
Like in case of the 3-bromoflavone (5) two isomers 
(12a and 13a) were isolated in ~ 3:1 ratio (12a: 50%, 
13a: 18% yield, respectively) (Scheme 4, Table 4). 
 
Scheme 4 Reaction of 3-bromochromone (11) with 1-allyl--D-
ribofuranose derivative 2a 
 
Scheme 5 Debenzylation of  1-allyl--D-ribofuranose derivative 3a 
and 12a 
Finally, the deprotection of flavone 3a and chromone 
12a derivatives were achieved by treatment with 
BCl3.Me2S complex
15
 in CH2Cl2 at low temperature, 
in order to preserve the unsaturated linker (Scheme 5). 
This protocol afforded the products up to 77% yield. 
In summary, in these transformations bromoflavones 
and -chromones were reacted with 1-allyl--D-
ribofuranose derivatives in the presence of palladium 
catalyst under phosphine-free condition, hereby 
providing the expected new, unknown structures in 
good yields. In some case the migration of the double 
bond was observed causing the formation of isomers, 
which compounds were successfully separated. These 
results clearly show the usefulness of this 
methodology in the synthesis of interesting target 
molecules with possible biological activity. The 
biological assays of the synthetized new carbohydrate-
flavone and -chromone derivatives already have been 
started. The investigations of the synthesis of other 
structurally novel derivatives are also in progress with 
other carbohydrates bearing different unsaturated side 
chain. 
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General procedure for the synthesis of flavone-ribose 
derivatives by Mizoroki-Heck reaction  
 
Condition A (Jeffery’s condition): A stirred, preheated mixture 
of bromoflavone (1a,b) (75 mg, 0.249 mmol), 3-(2,3,5-
tribenzyloxy--D-ribofuranozyl)-prop-1-ene (2a) (0.249 mmol, 
1.0 equiv) or 3-(3,5-dibenzyloxy--D-ribofuranozyl)-prop-1-
ene (2b) (0.249 mmol, 1.0 equiv), potassium carbonate (52 mg, 
0.375 mmol, 1.5 equiv), potassium chloride (19 mg, 0.250 
mmol, 1.0 equiv), tetrabutylammonium bromide (162 mg, 
0.500 mmol, 2.0 equiv) and palladium acetate (4 mg, 0.015 
mmol, 6 mol%) in dry DMF (5 mL) was heated at 110 oC for 2 
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hours under nitrogen atmosphere. The mixture was cooled then 
silica gel was added to the mixture and the solvent was 
evaporated under reduced pressure. Then it was purified by 
column chromatography to obtain the pure product. 
 
Condition B (classic Mizoroki-Heck condition): A stirred, 
preheated mixture of bromoflavone (1a,b) (75 mg, 0.249 
mmol), 3-(2,3,5-tribenzyloxy--D-ribofuranozyl)-prop-1-ene 
(2a) (0.249 mmol, 1.0 equiv), triethylamine (39 µL, 0.274 
mmol, 1.1 equiv), triphenylphosphine (7 mg, 0.025 mmol, 
10%) and palladium acetate (4 mg, 0.015 mmol, 6 mol%) in 
dry DMF (5 mL) was heated at 110 oC for 2 hours under 
nitrogen atmosphere. The mixture was cooled then silica gel 
was added to the mixture and the solvent was evaporated under 
reduced pressure. Then it was purified by column 
chromatography to obtain the pure product. 
 
7-((E)-3-((2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-
(benzyloxymethyl)tetrahydro-furan-2-yl)prop-1-enyl)-2-
phenyl-4H-chromen-4-one (3a)  
 
Condition A: 147 mg (89%), mp 126-127 °C, white crystal 
Condition B: 104 mg (63%), mp 126-127 °C, white crystal 
 
1H NMR (360 MHz, CDCl3): δ (ppm) = 2.45-2.63 (m, 2H), 
3.52 (m, 2H), 3.66 (t, J = 6.1 Hz, 1H), 3.93 (t, J = 4.6 Hz, 1H), 
4.21 (m, 2H), 4.42-4.64 (m, 6H), 6.44 (s, 2H), 6.80 (s, 1H), 
7.29 (m, 15H), 7.39 (s, 1H), 7.52 (m, 3H), 7.90 (m, 2H), 8.10 
(d, J = 8.2 Hz, 1H).  
13C NMR (90 MHz, CDCl3): δ (ppm) = 36.7, 70.3, 71.7, 72.0, 
73.3, 79.8, 80.0, 81.6, 107.6, 114.9, 122.5, 123.1, 125.6, 126.2, 
127.4, 127.6, 127.7, 128.0, 128.1, 128.3, 128.9, 130.5, 130.7, 
131.4, 131.8, 137.7, 138.0, 143.2, 156.5, 163.2, 178.1.  
IR (νmax, cm
−1): 2922, 2903, 2856, 1639, 1624, 1450, 1372, 
1101, 697.  
Anal. Calcd for C44H40O6: C, 79.50; H, 6.06. Found: C, 79.54; 
H, 6.10. 
 
6-((E)-3-((2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-
(benzyloxymethyl)tetrahydrofuran-2-yl)prop-1-enyl)-2-
phenyl-4H-chromen-4-one (4a) 
 
Condition A: 152 mg (92%), mp 89-90 °C, white crystal  
 
1H NMR (360 MHz, CDCl3): δ (ppm) = 2.52-2.59 (m, 2H), 
3.52 (m, 2H), 3.66 (t, J = 5.8 Hz, 1H), 3.91 (t, J = 4.6 Hz, 1H), 
4.15-4.22 (m, 2H), 4.43-4.62 (m, 6H), 6.25-6.34 (m, 1H), 6.37-
6.48 (m, 1H), 6.79 (s, 1H), 7.28 (m, 15H), 7.43 (t, J = 6.6 Hz, 
1H), 7.50 (m, 4H), 7.59 (d, J = 6.6 Hz, 1H), 7.90 (m, 2H), 8.08 
(s, 1H).  
13C NMR (90 MHz, CDCl3): δ (ppm) = 36.7, 70.2, 71.7, 71.9, 
73.3, 77.1, 79.8, 80.1, 81.3, 107.3, 118.1, 122.6, 123.7, 126.1, 
127.4, 127.6, 127.6, 127.7, 127.9, 128.2, 128.7, 128.9, 130.5, 
131.0, 131.4, 131.6, 134.7, 137.6, 137.7, 138.7, 155.2, 163.1, 
178.2.  
IR (νmax, cm
−1): 3029, 2875, 1639, 1614, 1451, 1360, 1097, 
731, 697;  
Anal. Calcd for C44H40O6: C, 79.50; H, 6.06. Found: C, 79.55; 
H, 6.08. 
 
6-((E)-3-((2S,4S,5R)-4-(benzyloxy)-5-
(benzyloxymethyl)tetrahydrofuran-2-yl)prop-1-enyl)-2-
phenyl-4H-chromen-4-one (4b) 
 
Condition A: 104 mg (75%), mp 82-83 °C, white crystal  
 
1H NMR (360 MHz, CDCl3): δ (ppm) = 1.67-1.80 (m, 2H), 
2.43-2.61 (m, 2H), 3.46-3.59 (m, 2H), 4.00-4.04 (m, 1H), 4.15-
4.17 (m, 1H), 4.23-4.29 (m, 1H), 4.50 (s, 2H), 4.56 (s, 2H), 
6.29-6.36 (m, 1H), 6.49-6.53 (d, J = 16.1 Hz, 1H), 6.79 (s, 1H), 
7.31 (m, 8H), 7.48 (m, 4H), 7.67 (d, J = 8.7 Hz, 1H), 7.89 (m, 
2H), 8.12 (d, J = 7.2 Hz, 1H).  
13C NMR (90 MHz, CDCl3): δ (ppm) = 37.6, 38.6, 70.9, 73.3, 
73.3, 78.1, 81.0, 83.5, 107.3, 118.1, 122.5, 123.7, 126.1, 127.5, 
128.1, 128.2, 128.7, 128.9, 130.4, 131.2, 131.5, 131.6, 134.8, 
138.0, 138.1, 155.2, 163.1, 178.3.  
IR (νmax, cm
−1): 3059, 3030, 2902, 2876, 1650, 1615, 1453, 
1360, 1097, 741, 698;  
Anal.  Calcd for C37H34O5: C, 79.55; H, 6.13; H, 6.06. Found: 
C, 79.57; H, 6.09. 
 
3-((E)-3-((2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-
(benzyloxymethyl)tetrahydrofuran-2-yl)prop-1-enyl)-2-
phenyl-4H-chromen-4-one (6a) 
 
Condition A: 40%, oil. 
 
1H NMR (360 MHz, CDCl3): δ (ppm) = 2.33-2.43 (m, 2H), 
3.52 (m, 2H), 3.69 (t, J = 5.4 Hz, 1H), 3.87 (t, J = 5.2 Hz, 1H), 
4.15 (m, 2H), 4.48-4.57 (m, 6H), 6.10 (d, J = 15.8 Hz, 1H), 
6.91 (m, 1H), 7.24 (m, 15H), 7.44 (m, 6H), 7.64 (m, 2H), 8.26 
(d, J = 7.6 Hz, 1H).  
13C NMR (100 MHz, CDCl3): δ (ppm) = 28.7, 70.5,  72.2, 73.4, 
77.8, 177.9, 81.4,  81.5,  81.9,  118.0, 119.6, 123.0,  124.9, 
128.5, 127.6, 127.7, 127.9,  128.1,  128.3,  128.4, 128.6, 129.9, 
130.4, 131.4, 133.2,  133.6,  138.1 , 138.3, 156.2, 162.4, 177.9.  
IR (νmax, cm
−1): 3059, 3027, 2919, 2896, 2880, 1648, 1631, 
1612, 1467, 1396, 1104,762, 696.  
Anal. Calcd for C44H40O6: C, 79.50; H, 6.06. Found: C, 79.55; 
H, 6.09. 
 
3-((E)-3-((2S,4S,5R)-4-(benzyloxy)-5-
(benzyloxymethyl)tetrahydrofuran-2-yl)prop-1-enyl)-2-
phenyl-4H-chromen-4-one (6b) 
 
Condition A: 29 mg (21%), colorless oil.  
 
1H NMR (360 MHz, CDCl3): δ (ppm) = 1.61-1.68 (m, 1H), 
2.06 (dd, J = 13.1 Hz, J = 4.9 Hz, 1H), 2.31-2.52 (m, 2H), 
3.41-3.55 (m, 2H), 3.99-4.01 (m, 1H), 4.08-4.10 (m, 1H), 4.16-
4.19 (m, 1H), 4.49 (s, 2H), 4.54 (s, 2H), 6.16 (d, J = 15.8 Hz, 
1H), 6.79-6.84 (m, 1H), 7.29 (m, 8H), 7.38 (m, 5H), 7.47 (m, 
2H), 7.56 (m, 3H), 8.26 (d,  J = 8.1 Hz, 1H).  
13C NMR (90 MHz, CDCl3): δ (ppm) = 37.5, 39.9, 70.9, 71.0, 
73.3, 78.2, 81.2, 83.4, 117.7, 117.9, 123.1, 123.5, 124.9, 126.2, 
126.3, 127.6, 128.3, 129.0, 129.7, 130.4, 133.2, 133.3, 138.2, 
155.5, 162.0, 177.5.  
IR (νmax, cm
−1): 2954, 2923, 2853, 1637, 1465, 1315, 1097, 
758, 696;  
Anal. Calcd for C37H34O5: C, 79.55; H, 6.13; H, 6.06. Found: 
C, 79.58; H, 6.15. 
 
General procedure for the synthesis of chromone-ribose 
derivatives by Mizoroki-Heck reaction  
 
Condition A (Jeffery’s condition): A stirred, preheated mixture 
of bromochromone (1a,b) (56 mg, 0.249 mmol), 3-(2,3,5-
tribenzyloxy--D-ribofuranozyl)-prop-1-ene (2a) (0.249 mmol, 
1.0 equiv) or 3-(3,5-dibenzyloxy--D-ribofuranozyl)-prop-1-
ene (2b) (0.249 mmol, 1.0 equiv), potassium carbonate (52 mg, 
0.375 mmol, 1.5 equiv), potassium chloride (19 mg, 0.250 
mmol, 1.0 equiv), tetrabutylammonium bromide (162 mg, 
0.500 mmol, 2.0 equiv) and palladium acetate (4 mg, 0.015 
mmol, 6 mol%) in dry DMF (5 mL) was heated at 110 oC for 2 
hours under nitrogen atmosphere. The mixture was cooled then 
silica gel was added to the mixture and the solvent was 
5   
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evaporated under reduced pressure. Then it was purified by 
column chromatography to obtain the pure product. 
 
7-((E)-3-((2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-
(benzyloxymethyl)tetrahydrofuran-2-yl)prop-1-enyl)-4H-
chromen-4-one (9a) 
 
Condition A: 115 mg (79%), colorless oil.  
 
1H NMR (360 MHz, CDCl3): δ (ppm) = 2.43-2.57 (m, 2H), 
3.50 (m, 2H), 3.61-3.66 (m, 1H), 3.90 (m, 1H), 4.19 (m, 2H), 
4.44-4.62 (m, 6H), 6.24 (d, J = 5.9 Hz, 1H), 6.38 (m, 2H), 7.27 
(m, 17H), 7.72 (d, J = 5.9 Hz, 1H), 8.05 (d, J = 8.2 Hz,1H).  
13C NMR (90 MHz, CDCl3): δ (ppm) = 36.5, 70.1, 71.5, 71.7, 
73.2, 76.8, 79.7, 79.9, 81.4, 112.7, 114.8, 122.8, 123.2, 125.5, 
127.3, 127.4, 127.5, 127.6, 127.8, 127.9, 128.1, 130.4, 137.5, 
137.6, 137.8, 137.9, 143.0, 155.0, 156.6, 177.0.  
IR (νmax, cm
−1): 3063, 3029, 2901, 2865, 1654, 1621, 1430, 
1127, 1027, 736, 698;  
Anal. Calcd for C38H36O6: C, 77.53; H, 6.16;. Found: C, 77.58; 
H, 6.19. 
 
3-((E)-3-((2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-
(benzyloxymethyl)tetrahydrofuran-2-yl)prop-1-enyl)-4H-
chromen-4-one (12a) 
 
Condition A: 73 mg (50%), colorless oil.  
 
1H NMR (360 MHz, CDCl3): δ (ppm) = 2.16-2.56 (m, 2H), 
3.53 (m, 2H), 3.68 (t, J = 5.6 Hz, 1H), 3.89 (t, J = 4.9 Hz, 1H), 
4.16 (m, 2H), 4.48-4.61 (m, 6H), 6.32 (d, J = 15.8 Hz, 1H), 
6.47 (m, 1H), 7.28 (m, 15H), 7.40 (m, 2H), 7.64 (t, J = 7.2 Hz, 
1H), 7.76 (s, 1H), 8.24 (d, J = 7.9 Hz, 1H).  
13C NMR (100 MHz, CDCl3): δ (ppm) = 37.4, 70.3, 71.7, 72.0, 
73.3, 77.1, 79.3, 80.5, 81.2, 117.9, 121.9, 122.4, 124.0, 124.9, 
126.1, 127.5, 127.6, 127.8, 128.0, 128.3, 128.4, 128.9, 133.3, 
137.8, 138.1, 151.9, 155.8, 176.4.  
IR (νmax, cm
−1): 3063, 3029, 2901, 2865, 1654, 1621, 1430, 
1127, 1027, 736, 698;  
Anal. Calcd for C38H36O6: C, 77.53; H, 6.16. Found: C, 77.58; 
H, 6.18. 
 
3-((E)-3-((2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-
(benzyloxymethyl)tetrahydrofuran-2-yl)allyl)-4H-chromen-
4-one (13a) 
Condition A: 26 mg (18%), colorless oil.  
  
1H NMR (360 MHz, CDCl3): δ (ppm) = 3.22 (m, 2H), 3.51 (d, 
2H), 3.66 (t, J = 6.1 Hz, 1H), 3.91 (t, J = 4.9 Hz, 1H), 4.00-
4.21 (m, 2H), 4.44-4.61 (m, 6H), 5.56 (dd, J = 15.3 Hz, J = 7.3 
Hz, 1H), 5.94 (dt, J = 15.3 Hz, J = 6.8 Hz, 1H), 7.28 (m, 15H), 
7.35 (m, 2H), 7.65 (m, 2H), 8.22 (d, J = 7.2 Hz, 1H).  
13C NMR (100 MHz, CDCl3): δ (ppm) = 29.8, 70.4, 72.0,  72.2 
, 73.5, 77.5, 81.4, 81.5, 81.6, 118.1, 123.0, 123.8, 125.0, 126.0, 
127.7, 127.8,  127.8, 128.0,  128.1, 128.3, 128.4 , 130.2 , 131.5 
, 133.5 , 138.0 , 137.9 , 152.8, 156.5, 177.5.  
IR (νmax, cm
−1): 2924, 2856, 1718, 1646, 1609, 1464, 1126, 
1100, 751, 698.  
Anal. Calcd for C38H36O6: C, 77.53; H, 6.16. Found: C, 77.55; 
H, 6.19. 
 
Supporting Information for this article is available online at 
http://www.thieme-connect.com/ejournals/toc/synthesis. 
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